Umbilical cord stem cells for advanced hepatitis B cirrhosis
Treatments studied
Part of Digestive system clinical trials.
This study tests whether stem cells from umbilical cord blood can safely help people with advanced liver scarring (cirrhosis) caused by hepatitis B. It may offer a new option for those who haven't improved with usual treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Adults aged 18 to 75
- Diagnosed with decompensated cirrhosis due to chronic hepatitis B
- No significant improvement after at least 3 months of standard medical care
- Low level of hepatitis B virus (HBV DNA ≤ 1000 IU/mL)
- Must sign an informed consent form
- Excludes other causes of cirrhosis, recent serious complications, and other major health issues
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an injection of stem cells from donated umbilical cords to see if it can help people with advanced liver scarring from hepatitis B. You may be able to join if standard treatments haven’t helped enough and you aren’t able to get a liver transplant.
This early-stage trial tests umbilical cord “mesenchymal” stem cells in people with liver scarring (cirrhosis) that is caused by hepatitis B. It may help improve liver function and related complications, but it is mainly designed to check safety and how well the treatment works.
This study tests a new treatment using stem cells for people with liver cirrhosis caused by alcohol, hepatitis B, or hepatitis C. The goal is to see if it is safe and if it can help improve liver function.
This trial tests umbilical-cord stem cells to see if they can improve outcomes in people with decompensated (worsening) cirrhosis. You may be considered if your liver disease is moderate to severe (MELD 15–30) and you do not have certain high-risk problems right now.
This Phase 1 study tests a stem cell product to see if it is safe and how it affects people with worsening hepatitis B-related cirrhosis. It may help researchers understand whether the treatment could improve liver function in this stage of illness.
This trial tests whether a stem cell infusion made from umbilical cord tissue can help people with severe liver failure caused by hepatitis B. The stem cells may reduce liver damage and improve recovery.
Hear when a new Decompensated Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.